• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Arena Pharmaceuticals Inc

+ Add to Watchlist

RN3:GR

3.370 EUR 0.113 3.24%

As of 09:25:17 ET on 07/29/2014.

Snapshot for Arena Pharmaceuticals Inc (RN3)

Open: 3.390 Day's Range: 3.365 - 3.499 Volume: 0
Previous Close: 3.483 52wk Range: 2.982 - 5.889 1-Yr Rtn: -34.28%

Stock Chart for RN3

No chart data available.
  • RN3:GR 3.365
  • 1D
  • 1M
  • 1Y
3.483
Interactive RN3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RN3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4380
Est. PEG Ratio -
Market Cap (M EUR) 740.22
Shares Outstanding (M) 219.65
30 Day Average Volume 169
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RN3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RN3

Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.

Jack LiefChairman/Pres/CEO/Co-FounderDominic P BehanExec VP/Chief Scientific Ofcr
Steven W SpectorExec VP/General Counsel/SecyRobert E HoffmanSenior VP:Finance/CFO
More Company Profile & Key Executives for RN3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil